Review on Chemistry, Pharmacology and Toxicity of Paracetamol

Document Type : Original Article

Authors

1 Department of Forensic Medicine and Clinical Toxicology, Faculty of Medicine, Sohag University.

2 Department of Forensic Medicine and Clinical Toxicology, Faculty of Medicine, Sohag University, Egypt.

3 Department of Pathology, Faculty of Medicine, Sohag University.Sohag, Egypt .

Main Subjects


  1. Anderson, B.J. (2008): Paracetamol (Acetaminophen): mechanisms of action. Paediatr. Anaesth., 18:p.915–921.
  2. Bateman, D. N. (2015): Paracetamol poisoning: beyond the nomogram. Br. J. Clin. Pharmacol., 80(1): p.  45–50.
  3. Bateman, D.N.; Carroll, R.; Pettie, J.; Yamamoto, T.; Elamin, M.E. and Peart, L.(2014): Effect of the UK’s revised paracetamol poisoning management guidelines on admissions, adverse reactions and costs of treatment. Br. J. Clin. Pharmacol., 78:p. 610–618.
  4. Bernal, W., and Wendon, J. (2003): More on serum phosphate and prognosis of acute liver failure. Hepatology, 38:p. 533-534.
  5. Bernal, W.; Donaldson, N.; Wyncoll, D. and Wendon, J. (2002): Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study. Lancet, 359(9306): p.558-563.
  6. Buehler, M.C. and Curry, S.C. (2005): False-positive acetaminophen levels associated with hyperbilirubinemia. Clin. Toxicol.,43: p.167–170. 
  7. Chen, Y.G.; Lin, C.L.; Dai,  M.S.; Chang, P.Y.; Chen, J.H.; Huang, T.C.; Wu, Y.Y. and Kao, C.H.(2015): Risk of acute kidney injury and long-term outcome in patients with acetaminophen intoxication: A nationwide population-based retrospective cohort study. Medicine, 94(46):p. 2040-2046. 
  8. Chun, L.J.; Tong, M.J.; Busuttil, R.W.and Hiatt, J.R. (2009): Acetaminophen hepatotoxicity and acute liver failure. J. Clin. Gastroenterol., 43:p.342-349.
  9. Chyka, P.A.; Seger, D.; Krenzelok, E.P. and Vale, J.A. (2005): Position paper: Single-dose activated charcoal. Clin.Toxicol., 43(2):p. 61-87.
  10. Courade ,J.P.; Martin, K.; Besse, D.; Delchambre, C.; Hanoun, N.; Hamon, M.; Eschalier, A.; Caussade, F. and Cloarec, A. (2001) :Acetaminophen distribution in the rat central nervous system. Life Sci. 69:p. 1455–1464.
  11. Daly, F.F.; O’Malley, G.F.; Heard, K.; Bogdan, G.M. and Dart, R.C (2004): Prospective evaluation of repeated supratherapeutic acetaminophen (paracetamol) ingestion. Ann. Emerg. Med., 44:p. 393-398.
  12. Dargan, P.I. and Jones, A.L. (2002): Acetaminophen poisoning: an update for the intensivist. Crit. Care, (2):p.108-110.
  13. Dart, R.C.; Erdman, A.R.; Olson, K.R.; Manoguerra, A.S.; Chyka, P.A.; Caravati, E.M.; Wax, P.M.; Keyes, D.C.; Woolf, A.D.; Scharman, E.J.; Booze, L.L and Troutman, W.G. (2006):Acetaminophen poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin.Tox., 44:p.1-18.
  14. Farrell, S.E. and Defendi, G.L. (2018):  Acetaminophen toxicity treatment & management. Available at https://emedicine.medscape.com/article/820200-overview.
  15. Ferner, R.E.; Dear, J.W. and Bateman, D.N. (2011): Management of paracetamol poisoning. B.M.J., 342:p.2218-2227.
  16. Gelotte, C.K.; Auiler, J.F.; Lynch, J.M.; Temple, A.R. and Slattery, J.T. (2007): Disposition of acetaminophen at 4, 6, and 8 g/day for 3 days in healthy young adults. Clin.Pharmacol.Ther., 81(6):p. 840–848.
  17. Green, T.J.; Sivilotti, M.L.; Langmann, C.; Yarema, M.; Juurlink, D.; Burns, M.J. and Johnson, D.W. (2010):  When do the aminotransferases rise after acute acetaminophen overdose? Clin.Toxicol., 48:p. 787-792.
  18. Heard, K.J. (2008): Acetylcysteine for acetaminophen poisoning. N. Engl. J. Med., 359: p. 285-292.
  19. Hodgman, M.J. and Garrard, A.R. (2012): A review of acetaminophen poisoning. Crit.Care Clin., 28: p.499-516.
  20. Jaeschke, H.; Williams, C.D.; Ramachandran, A. and Bajt, M.L. (2012): Acetaminophen hepatotoxicity and repair: the role of sterile inflammation and innate immunity. Liver Int., 32:p. 8–20.
  21. James, L.P.; Capparelli, E.V.; Simpson,  P.M.; Letzig, L.; Roberts, D.;  Hinson, J.A.;  Kearns, G.L.; Blumer, J.L. and Sullivan, J.E. (2008): Acetaminophen-associated hepatic injury: evaluation of acetaminophen protein adducts in children and adolescents with acetaminophen overdose. Clin. Pharmacol.Ther., 84(6): p. 684-690
  22. James, L.P.; Chiew, A.; Abdel-Rahman, S.M.; Letzig, L.; Graudins, A.; Day, P. and Roberts, D. (2013): Acetaminophen protein adduct formation following low-dose acetaminophen exposure: comparison of immediate-release vs extended-release formulations. Eur. J. Clin. Pharmacol., 69:p.851–857.
  23. Ji, P.; Wang, Y.;  Li, Z.; Doddapaneni, S.; Hertz, S.; Furness, S. and Sahajwalla, C.G. (2012):  Regulatory review of acetaminophen clinical pharmacology in young pediatric patients. J. Pharm. Sci., 101:p.4383–4389.
  24. Kanno, S.; Tomizawa, A.; Hiura, T.; Osanai, Y.; Kakuta, M.; Kitajima, Y.; Koiwai, K.; Ohtake, T.; Ujibe, M. and Ishikawa, M. (2006): Melatonin protects on toxicity by acetaminophen
  25. Kozer, E. and Koren, G. (2001): Management of paracetamol overdose: current controversies. Drug Safety, 24:p.503-512. 
  26. Kumpulainen, E.; Kokki, H.; Halonen, T.; Heikkinen, M.; Savolainen, J. and Laisalmi, M. (2007): Paracetamol (acetaminophen) penetrates readily into the cerebrospinal fluid of children after intravenous administration. Pediatrics, 119:p. 766–771.
  27. Larson, A.M. (2007): Acetaminophen hepatotoxicity. Clin.Liver Dis.,11: p.525-548.
  28. McGill, M.R. and Jaeschke, H. (2013): Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis. Pharm Res., 30:p.2174–2187.
  29. McGill, S.K. and McGill, M.R. (2018): Extrahepatic toxicity of acetaminophen: a critical evaluation of the evidence and proposed mechanisms. J. Clin. Transl. Res., 3(3):p. 5-31.
  30. McGovern, A.J.; Vitkovitsky, I.V.; Jones, D.L. and Mullins, M.E. (2015): Can AST/ALT ratio indicates recovery after acute paracetamol poisoning? Clin. Toxicol., 53:p.164–167. 
  31. Michael, J.; Hodgman, M.D. and Alexander R. (2012):  A review of acetaminophen poisoning. Crit.Care Clin., 28:p.  499–516.
  32. Pakravan, N.; Simpson, K.; Waring, W.S.; Bates, C.M. and Bateman, D.N. (2009): Renal injury at first presentation as a predictor for poor outcome in severe paracetamol poisoning referred to a liver transplant unit. Eur.J.Clin. Pharmacol., 65: p.163-168.
  33. Patrick, J. A., and Eugene, R. S. (2007): Acetaminophen safety and hepatotoxicity – where do we go from here. Expert Opinion on Drug Safety journal, 6:p.341:355.
  34. Prescott, L.F. (2001): Paracetamol (acetaminophen): a critical bibliographic review, 2nd ed. Taylor & Francis, London:p.1001-1100.
  35. Roberts, E.A. (2007): Drug-induced liver disease. In: Suchy, F.J.; Sokol, R.J. and Balistreri, W.F.(eds.): Liver disease in children. 3rd ed. Cambridge university press, USA:p. 478–512.
  36. Rumack, B.H. (2002): Acetaminophen hepatotoxicity: the first 35 years. J.Toxicol.Clin. Toxicol., 40:p.3–20.
  37. Schilling, A.; Corey, R.; Leonard, M. andEghtesad, B. (2010): Acetaminophen: old drug, new warnings. Cleve. Clin. J. Med., 77(1): p.19-27.
  38. Stockler, M.; Vardy, J.; Pillai, A. and Warr, D. (2004): Acetaminophen (paracetamol) improves pain and well-being in people with advanced cancer already receiving a strong opioid regimen: a randomized, double-blind, placebo-controlled cross-over trial. J. Clin. Oncol., 22:p. 3389–3394.
  39. Swierkosz, T.A.; Jordan, L.; Mcbride, M.; Mcgough, K.; Devlin, J. and Botting, R.M. (2002):Actions of paracetamol on cyclooxygenases in tissue and cell homogenates of mouse and rabbit.Med. Sci. Monit., 8(12):p.496-503.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

  1. Whyte, I.M.; Francis, B. and Dawson, A.H. (2007): Safety and efficacy of intravenous N-acetylcysteine for acetaminophen overdose: analysis of the Hunter Area Toxicology Service (HATS) database. Curr.Med. Res.Opin. 23(10):p.2359-2368
  2. Yuan, L. and Kaplowitz, N. (2013): Mechanisms of drug-induced liver injury. Clin.Liver Dis., 17:p. 507–518.
  3. Zyoud, S.H.; Awang, R.; Sulaiman, S.A. and Al-Jabi, S.W. (2011): Impact of serum acetaminophen concentration on changes in serum potassium, creatinine and urea concentrations among patients with acetaminophen overdose. Pharmacoepidemiol. Drug Saf., 20(2):p. 203-208.